Literature DB >> 28119967

A GSH-activatable ruthenium(ii)-azo photosensitizer for two-photon photodynamic therapy.

Leli Zeng1, Shi Kuang1, Guanying Li1, Chengzhi Jin1, Liangnian Ji1, Hui Chao1.   

Abstract

A glutathione (GSH)-activatable ruthenium(ii)-azo photosensitizer was prepared. The complex had low toxicity towards cells under dark conditions. It exhibited excellent phototoxicity under two-photon excitation (810 nm) and thus was developed as a two-photon photodynamic anticancer agent for cancer therapy.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28119967     DOI： 10.1039/c6cc10330h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  9 in total

Review 1.  The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.

Authors:  Leli Zeng; Pranav Gupta; Yanglu Chen; Enju Wang; Liangnian Ji; Hui Chao; Zhe-Sheng Chen
Journal:  Chem Soc Rev       Date:  2017-10-02       Impact factor: 54.564

2.  DNA Interaction, DNA Photocleavage, Photocytotoxicity In Vitro, and Molecular Docking of Naphthyl-Appended Ruthenium Complexes.

Authors:  Xia Hu; Qian Luo; Yao Qin; Yao Wu; Xue-Wen Liu
Journal:  Molecules       Date:  2022-06-08       Impact factor: 4.927

Review 3.  Recent advances in noble metal complex based photodynamic therapy.

Authors:  Yanping Wu; Shumeng Li; Yuncong Chen; Weijiang He; Zijian Guo
Journal:  Chem Sci       Date:  2022-04-01       Impact factor: 9.969

4.  Novel iridium(III) iminopyridine complexes: synthetic, catalytic, and in vitro anticancer activity studies.

Authors:  Deliang Kong; Meng Tian; Lihua Guo; Xicheng Liu; Shumiao Zhang; Yameng Song; Xin Meng; Shu Wu; Lingzi Zhang; Zhe Liu
Journal:  J Biol Inorg Chem       Date:  2018-06-11       Impact factor: 3.358

Review 5.  Applications of Ruthenium Complex in Tumor Diagnosis and Therapy.

Authors:  Ke Lin; Zi-Zhuo Zhao; Hua-Ben Bo; Xiao-Juan Hao; Jin-Quan Wang
Journal:  Front Pharmacol       Date:  2018-11-19       Impact factor: 5.810

6.  Ligand-centred redox activation of inert organoiridium anticancer catalysts.

Authors:  Wen-Ying Zhang; Samya Banerjee; George M Hughes; Hannah E Bridgewater; Ji-Inn Song; Ben G Breeze; Guy J Clarkson; James P C Coverdale; Carlos Sanchez-Cano; Fortuna Ponte; Emilia Sicilia; Peter J Sadler
Journal:  Chem Sci       Date:  2020-05-15       Impact factor: 9.825

7.  Photoinduced DNA Cleavage and Photocytotoxic of Phenanthroline-Based Ligand Ruthenium Compounds.

Authors:  Xia Hu; Ning-Yi Liu; Yuan-Qing Deng; Shan Wang; Ting Liu; Xue-Wen Liu
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

8.  Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-induced DNA damage.

Authors:  Yuyang Zhou; Ying Xu; Lunjie Lu; Jingyang Ni; Jihua Nie; Jianping Cao; Yang Jiao; Qi Zhang
Journal:  Theranostics       Date:  2019-09-18       Impact factor: 11.556

9.  Synthesis, Identification, and Biological Study for Some Complexes of Azo Dye Having Theophylline.

Authors:  Hasan Mohammed
Journal:  ScientificWorldJournal       Date:  2021-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.